Inventor · disambiguated record
Jing Deng
Also filed as: DENG JING · DENG JING-ZHEN
13 granted patents·13 pending applications·21 citations·filing 2006–2024
87Inventor score
Files withUNIV MICHIGAN REGENTS8ASCENTAGE PHARMA SUZHOU CO LTD5FOGHORN THERAPEUTICS INC5ZHOU WENQIANG3GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPEMENT LTD1
Top patents by PatentIndex Score
26 records- 0195US11147885B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2020·Granted Oct 19, 2021·5 cites·20 claims
- 0294US10632209B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Apr 28, 2020·9 cites·18 claims
- 0389US11833210B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Dec 5, 2023·1 cites·19 claims
- 0489US11786602B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 0587US11110177B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Sep 7, 2021·2 cites·16 claims
- 0685US12285490B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 0772US9266911B2Camptothecin derivative, and preparation method thereof, and pharmaceutical composition and applicationZHOU WENQIANG·Filed 2013·Granted Feb 23, 2016·3 cites·14 claims
- 0872US2024390401A1Combination of bcl-2/bcl-xl inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 0967US12083136B2Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Sep 10, 2024·0 cites·4 claims
- 1064US2024245645A1Ash1l inhibitors and methods and treatment therewithUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 1162US2025304596A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1261US2025302832A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1359US2025099440A1A pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1457US2024376121A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1554US2024024488A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1653US2023348452A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1752US12194024B2Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating diseaseASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jan 14, 2025·0 cites·5 claims
- 1851US11883381B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 30, 2024·0 cites·13 claims
- 1949US2022233558A1Method and composition for predicting efficacy of bcl2/bcl-xl inhibitors on cancerASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 2048US2023002492A1Anti-human programmed cell death ligand-1 (pd-l1) antibody and use thereofSIMCERE SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2144US2023192797A1Human il-15 mutant and uses thereofJIANGSU SIMCERE PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2244US2006235047A1Antibacterial compounds and uses thereofPINNACLE PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 2343US9334299B2Water-soluble camptothecin derivative, pharmaceutical composition and use thereofZHOU WENQIANG·Filed 2011·Granted May 10, 2016·0 cites·20 claims
- 2435US2016375042A1Use of camptothecin derivative in preparing pharmaceutical used for treating multiple myelomaZHOU WENQIANG·Filed 2014·Application pending·0 cites
- 2534US9902715B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Feb 27, 2018·0 cites·21 claims
- 2628US9902735B2Heteroaryl substituted compounds as RORγ inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPEMENT LTD·Filed 2015·Granted Feb 27, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Jing Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →